Stocks and InvestingStocks and Investing
Tue, October 18, 2022
Mon, October 17, 2022
Sat, October 15, 2022
Fri, October 14, 2022

Vikram Purohit Maintained (AXSM) at Hold with Increased Target to $74 on, Oct 14th, 2022


Published on 2024-10-27 23:24:00 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Increased Target from $71 to $74 on, Oct 14th, 2022.

Vikram has made no other calls on AXSM in the last 4 months.



There are 6 other peers that have a rating on AXSM. Out of the 6 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Vikram


  • Chris Howerton of "Jefferies" Maintained at Strong Buy with Decreased Target to $90 on, Friday, September 30th, 2022
  • Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $76 on, Wednesday, September 7th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022